| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.shardacropchem.com | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 3,153.21 Cr. | |
| Earnings per share (EPS) | 26.53 | Trailing Twelve Months Ending 2021-06 |
| Price-Earning Ratio (PE) | 13.18 | Trailing Twelve Months Ending 2021-06 |
| Industry PE | 48.49 | Trailing Twelve Months Ending 2021-06 |
| Book Value / Share | 183.15 | Trailing Twelve Months Ending 2021-06 |
| Price to Book Value | 1.91 | Calculated using Price: 349.50 |
| Dividend Yield | 1.43 | Period Ending 2021-03 |
| No. of Shares Subscribed | 9.02 Cr. | 90,220,495 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
Sharda Cropchem was incorporated as Sharda Worldwide Exports on March 12, 2004, in Mumbai, as a private limited company under the Companies Act, 1956. Initially the company began its operations through two sole proprietary firms, each set up by Ramprakash V. Bubna and Sharda R. Bubna. After incorporation as Sharda Worldwide Exports in 2004, the generic agrochemical business and non-agrochemical business conducted by both firms were transferred to the company. The company was converted into a public limited company and changed its name to Sharda Cropchem on September 18, 2013. Sharda Cropchem is a crop protection chemical company engaged in the marketing and distribution of a wide range of formulations and generic active ingredients globally. It is also involved in order based procurement and supply of Belts, general chemicals, dyes and dye intermediates. It procures these non-agrochemical products, primarily, from the manufacturers in China or India and supplies them in over 35 countries across Australia, Asia, Europe, North America and Latin America. The company has recently entered into the biocide segment and has acquired several registrations from the existing registration holders, primarily, in Europe. As of August 5, 2014, the company had over 180 Good Laboratory Practices (GLP) certified dossiers and as of July 15, 2014, it owned over 1,040 registrations for formulations and over 155 registrations for generic active ingredients across Europe, NAFTA, Latin America and Rest of the World. The company’s library of dossiers gives it a competitive edge and facilitates in seeking registrations in different countries in a time efficient manner. This also fosters its ability to operate in and distribute diversified range of formulations and generic active ingredients globally including highly regulated markets, which would not be permitted without such registrations. As of August 5, 2014, it has filed over 500 applications for seeking registrations globally which are pending at different stages. Milestones: In November 2011, the company acquired 76% stake in Axis Crop Science, which is a company focused on marketing and distribution of formulations in India. 2013 • The Company gets listed on BSE India under the List 'B' Group Securities. |
||
Company Profile
Sharda Cropchem was incorporated as Sharda Worldwide Exports on March 12, 2004, in Mumbai, as a private limited company under the Companies Act, 1956. Initially the company began its operations through two sole proprietary firms, each set up by Ramprakash V. Bubna and Sharda R. Bubna. After incorporation as Sharda Worldwide Exports in 2004, the generic agrochemical business and non-agrochemical business conducted by both firms were transferred to the company. The company was converted into a public limited company and changed its name to Sharda Cropchem on September 18, 2013.
Sharda Cropchem is a crop protection chemical company engaged in the marketing and distribution of a wide range of formulations and generic active ingredients globally. It is also involved in order based procurement and supply of Belts, general chemicals, dyes and dye intermediates. It procures these non-agrochemical products, primarily, from the manufacturers in China or India and supplies them in over 35 countries across Australia, Asia, Europe, North America and Latin America. The company has recently entered into the biocide segment and has acquired several registrations from the existing registration holders, primarily, in Europe.
As of August 5, 2014, the company had over 180 Good Laboratory Practices (GLP) certified dossiers and as of July 15, 2014, it owned over 1,040 registrations for formulations and over 155 registrations for generic active ingredients across Europe, NAFTA, Latin America and Rest of the World.
The company’s library of dossiers gives it a competitive edge and facilitates in seeking registrations in different countries in a time efficient manner. This also fosters its ability to operate in and distribute diversified range of formulations and generic active ingredients globally including highly regulated markets, which would not be permitted without such registrations. As of August 5, 2014, it has filed over 500 applications for seeking registrations globally which are pending at different stages.
Milestones:
In November 2011, the company acquired 76% stake in Axis Crop Science, which is a company focused on marketing and distribution of formulations in India.
2013
• The Company changed its name from Sharda Worldwide Exports Private Limited to Sharda Cropchem Private Limited and thereafter to Sharda Cropchem Limited, upon conversion to a public limited company
2014
• The Company gets listed on BSE India under the List 'B' Group Securities.
• The Board has adopted the Whistle Blower Policy.
| 1 Day |
|
+0.44% |
| 1 Week |
|
+1.86% |
| 1 Month |
|
+1.65% |
| 3 Month |
|
+16.84% |
| 6 Month |
|
+23.54% |
| 1 Year |
|
+15.10% |
| 2 Year |
|
+29.04% |
| 5 Year |
|
-8.96% |
| 9 years | 2012-03 | 2013-03 | 2014-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | 19.11 | 19.55 | 21.74 | 21.57 | 18.22 | 14.58 | 12.26 | 15.19 | ||
| Return on Capital Employed (%) | 23.90 | 25.89 | 29.48 | 31.81 | 26.71 | 19.72 | 14.95 | 21.11 | ||
| Return on Assets (%) | 12.12 | 11.76 | 13.00 | 11.17 | 8.65 | 7.00 | 6.33 | 7.70 |
| Particulars | 9 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Shh. Funds | 466 | 556 | 655 | 805 | 960 | 1,135 | 1,284 | 1,403 | 1,614 | |
| Non Curr. Liab. | 9 | 10 | 149 | 181 | 256 | 317 | 404 | 435 | 507 | |
| Curr. Liab. | 320 | 348 | 370 | 542 | 663 | 1,078 | 822 | 856 | 1,140 | |
| Minority Int. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Equity & Liab. | 794 | 914 | 1,174 | 1,529 | 1,879 | 2,530 | 2,510 | 2,695 | 3,261 | |
| Non Curr. Assets | 179 | 231 | 410 | 513 | 670 | 891 | 962 | 1,014 | 1,161 | |
| Curr. Assets | 616 | 683 | 764 | 1,015 | 1,209 | 1,639 | 1,548 | 1,681 | 2,100 | |
| Misc. Exp. not W/O | ||||||||||
| Total Assets | 794 | 914 | 1,174 | 1,529 | 1,879 | 2,530 | 2,510 | 2,695 | 3,261 |
| Particulars | 9 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Net Sales | 776 | 790 | 1,061 | 1,222 | 1,399 | 1,707 | 1,998 | 2,003 | 2,396 | |
| Other Income | 15 | 33 | 29 | 25 | 16 | 17 | 21 | 43 | 46 | |
| Total Income | 791 | 823 | 1,090 | 1,248 | 1,415 | 1,723 | 2,018 | 2,046 | 2,442 | |
| Total Expenditure | -637 | -631 | -882 | -943 | -1,078 | -1,351 | -1,664 | -1,708 | -1,945 | |
| PBIDT | 154 | 192 | 208 | 305 | 337 | 372 | 355 | 338 | 496 | |
| Interest | 0 | -8 | -9 | -8 | -9 | -15 | -20 | -16 | -16 | |
| Depreciation | -37 | -29 | -23 | -35 | -56 | -70 | -99 | -137 | -170 | |
| Taxation | -33 | -44 | -52 | -86 | -81 | -96 | -59 | -20 | -80 | |
| Exceptional Items | ||||||||||
| PAT | 84 | 111 | 123 | 175 | 190 | 191 | 176 | 165 | 229 |
| Particulars | 9 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | 84 | 156 | 46 | 197 | 181 | 17 | 556 | 146 | 246 | |
| Cash Fr. Inv. | -113 | -151 | -22 | -120 | -104 | -163 | -360 | -68 | -282 | |
| Cash Fr. Finan. | 32 | -22 | -24 | -89 | -38 | 132 | -215 | -60 | 43 | |
| Net Change | 3 | -16 | 0 | -13 | 40 | -14 | -19 | 19 | 8 | |
| Cash & Cash Eqvt | 32 | 22 | 25 | 32 | 72 | 61 | 51 | 78 | 86 |
|
Thu, 29 Jul 2021
Shareholder Meeting / Postal Ballot-Outcome of AGM We are pleased to inform you that the 18th Annual General Meeting of the Members of the Company was held on Thursday July 29 2021 at 12:00 Noon through Video Conferencing / Other Audio Video Means. Enclosed herewith please find the proceedings of the AGM pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Kindly take the same on record. |
|
Wed, 28 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication The Un-audited Financial Results (Standalone & Consolidated) for the Quarter ended June 30 2021 have been approved and taken on record by the Board of Directors in their meeting held on 27th July 2021. The same was published in the following newspapers on 28th July 2021: - 1) The Economic Times Mumbai Edition in English Newspaper; 2) Maharashtra Times Mumbai Edition in Marathi Newspaper. Please find enclosed the newspaper advertisement for your record. |
|
Tue, 27 Jul 2021
Announcement under Regulation 30 (LODR)-Investor Presentation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we are enclosing herewith the presentation made to the Investors/Analysts Call on the Financial Results of the Company for the Quarter ended June 30 2021. The presentation is also being uploaded on the website of the Company www.shardacropchem.com in accordance with Regulation 46 of the Listing Regulations. |
| Thu, 29 Jul 2021 |
Stock Outperforming Benchmark Index in both 1 Week and 3 Month
|
Stock Outperforming Sectoral Index in both 1 Week and 3 Month
|
Decreasing Relative Strength - Benchmark index
|
Close Within 2 Year High Zone
|
Both SRS And ARS Above Zero
|
Equities
M.F.
Sectors